Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.59199386 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.59199386 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.30447346 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.30447346 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.90183267 |
6 | indole-containing compound catabolic process (GO:0042436) | 6.26693647 |
7 | indolalkylamine catabolic process (GO:0046218) | 6.26693647 |
8 | tryptophan catabolic process (GO:0006569) | 6.26693647 |
9 | glyoxylate metabolic process (GO:0046487) | 6.24071236 |
10 | epoxygenase P450 pathway (GO:0019373) | 6.21636531 |
11 | kynurenine metabolic process (GO:0070189) | 5.98679301 |
12 | tryptophan metabolic process (GO:0006568) | 5.90120238 |
13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.85948979 |
14 | cysteine metabolic process (GO:0006534) | 5.76326314 |
15 | bile acid biosynthetic process (GO:0006699) | 5.75505139 |
16 | urea metabolic process (GO:0019627) | 5.53052487 |
17 | urea cycle (GO:0000050) | 5.53052487 |
18 | glycosphingolipid catabolic process (GO:0046479) | 5.42260363 |
19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.40091187 |
20 | sulfur amino acid catabolic process (GO:0000098) | 5.38980247 |
21 | serine family amino acid catabolic process (GO:0009071) | 5.34893339 |
22 | lysine metabolic process (GO:0006553) | 5.33974444 |
23 | lysine catabolic process (GO:0006554) | 5.33974444 |
24 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.29503464 |
25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.24287997 |
26 | negative regulation of fibrinolysis (GO:0051918) | 5.21185981 |
27 | high-density lipoprotein particle remodeling (GO:0034375) | 5.16813783 |
28 | omega-hydroxylase P450 pathway (GO:0097267) | 5.12092349 |
29 | nitrogen cycle metabolic process (GO:0071941) | 5.10832451 |
30 | homocysteine metabolic process (GO:0050667) | 5.07237187 |
31 | aromatic amino acid family metabolic process (GO:0009072) | 5.02288860 |
32 | glycolipid catabolic process (GO:0019377) | 5.00229606 |
33 | regulation of fibrinolysis (GO:0051917) | 4.98360266 |
34 | protein carboxylation (GO:0018214) | 4.97351847 |
35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.97351847 |
36 | amino-acid betaine metabolic process (GO:0006577) | 4.93996778 |
37 | bile acid metabolic process (GO:0008206) | 4.88601014 |
38 | complement activation, alternative pathway (GO:0006957) | 4.87509651 |
39 | regulation of protein activation cascade (GO:2000257) | 4.84102608 |
40 | oligosaccharide catabolic process (GO:0009313) | 4.81758406 |
41 | alpha-amino acid catabolic process (GO:1901606) | 4.74445569 |
42 | tyrosine metabolic process (GO:0006570) | 4.72454467 |
43 | cellular ketone body metabolic process (GO:0046950) | 4.63640756 |
44 | regulation of triglyceride catabolic process (GO:0010896) | 4.58335335 |
45 | regulation of cholesterol esterification (GO:0010872) | 4.57556544 |
46 | drug catabolic process (GO:0042737) | 4.51149736 |
47 | regulation of complement activation (GO:0030449) | 4.50511305 |
48 | reverse cholesterol transport (GO:0043691) | 4.50239171 |
49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.45260225 |
50 | protein-lipid complex remodeling (GO:0034368) | 4.45260225 |
51 | macromolecular complex remodeling (GO:0034367) | 4.45260225 |
52 | drug transmembrane transport (GO:0006855) | 4.43298810 |
53 | indolalkylamine metabolic process (GO:0006586) | 4.43235011 |
54 | serine family amino acid metabolic process (GO:0009069) | 4.42653255 |
55 | cellular amino acid catabolic process (GO:0009063) | 4.41686624 |
56 | urate metabolic process (GO:0046415) | 4.41644360 |
57 | negative regulation of sterol transport (GO:0032372) | 4.39733057 |
58 | negative regulation of cholesterol transport (GO:0032375) | 4.39733057 |
59 | ceramide catabolic process (GO:0046514) | 4.38909211 |
60 | glutamate metabolic process (GO:0006536) | 4.36798850 |
61 | cellular modified amino acid catabolic process (GO:0042219) | 4.32728059 |
62 | triglyceride homeostasis (GO:0070328) | 4.32397222 |
63 | acylglycerol homeostasis (GO:0055090) | 4.32397222 |
64 | glycine metabolic process (GO:0006544) | 4.31646059 |
65 | cellular biogenic amine catabolic process (GO:0042402) | 4.29933844 |
66 | amine catabolic process (GO:0009310) | 4.29933844 |
67 | cellular glucuronidation (GO:0052695) | 4.24465940 |
68 | coenzyme catabolic process (GO:0009109) | 4.24003886 |
69 | benzene-containing compound metabolic process (GO:0042537) | 4.22114015 |
70 | phospholipid efflux (GO:0033700) | 4.22056761 |
71 | angiotensin maturation (GO:0002003) | 4.22004718 |
72 | serine family amino acid biosynthetic process (GO:0009070) | 4.17745404 |
73 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.14022334 |
74 | bile acid and bile salt transport (GO:0015721) | 4.09705767 |
75 | plasma lipoprotein particle clearance (GO:0034381) | 4.09510946 |
76 | short-chain fatty acid metabolic process (GO:0046459) | 4.06166307 |
77 | aldehyde catabolic process (GO:0046185) | 4.06145971 |
78 | exogenous drug catabolic process (GO:0042738) | 4.05482076 |
79 | ketone body metabolic process (GO:1902224) | 4.01070854 |
80 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00491988 |
81 | imidazole-containing compound metabolic process (GO:0052803) | 3.99900106 |
82 | ethanol oxidation (GO:0006069) | 3.97280939 |
83 | aspartate family amino acid catabolic process (GO:0009068) | 3.96465759 |
84 | arginine metabolic process (GO:0006525) | 3.94866408 |
85 | organic acid catabolic process (GO:0016054) | 3.89567399 |
86 | carboxylic acid catabolic process (GO:0046395) | 3.89567399 |
87 | cholesterol efflux (GO:0033344) | 3.84746250 |
88 | acetyl-CoA metabolic process (GO:0006084) | 3.84688597 |
89 | glucuronate metabolic process (GO:0019585) | 3.84046913 |
90 | uronic acid metabolic process (GO:0006063) | 3.84046913 |
91 | peptide catabolic process (GO:0043171) | 3.82546418 |
92 | fibrinolysis (GO:0042730) | 3.74124469 |
93 | 2-oxoglutarate metabolic process (GO:0006103) | 3.72213021 |
94 | carnitine metabolic process (GO:0009437) | 3.72115304 |
95 | plasma lipoprotein particle assembly (GO:0034377) | 3.70863080 |
96 | drug transport (GO:0015893) | 3.70452593 |
97 | low-density lipoprotein particle remodeling (GO:0034374) | 3.67131167 |
98 | flavonoid metabolic process (GO:0009812) | 3.67044267 |
99 | cofactor catabolic process (GO:0051187) | 3.63966419 |
100 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63761010 |
101 | fatty acid beta-oxidation (GO:0006635) | 3.63580584 |
102 | fatty acid oxidation (GO:0019395) | 3.63497576 |
103 | hormone catabolic process (GO:0042447) | 3.63290262 |
104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62757628 |
105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62757628 |
106 | monocarboxylic acid catabolic process (GO:0072329) | 3.61562450 |
107 | regulation of cholesterol homeostasis (GO:2000188) | 3.59828655 |
108 | phospholipid homeostasis (GO:0055091) | 3.58402708 |
109 | cholesterol homeostasis (GO:0042632) | 3.57972871 |
110 | drug metabolic process (GO:0017144) | 3.57683289 |
111 | lipid oxidation (GO:0034440) | 3.56424409 |
112 | ethanol metabolic process (GO:0006067) | 3.50180566 |
113 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.41568429 |
114 | complement activation (GO:0006956) | 3.38794732 |
115 | NADH metabolic process (GO:0006734) | 3.37016851 |
116 | amino sugar catabolic process (GO:0046348) | 3.32793902 |
117 | sphingolipid catabolic process (GO:0030149) | 3.29446492 |
118 | membrane lipid catabolic process (GO:0046466) | 3.26199871 |
119 | protein activation cascade (GO:0072376) | 3.26082588 |
120 | phenylpropanoid metabolic process (GO:0009698) | 3.25552163 |
121 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.24993019 |
122 | complement activation, classical pathway (GO:0006958) | 3.24197474 |
123 | acute-phase response (GO:0006953) | 3.22175629 |
124 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.19634249 |
125 | plasma lipoprotein particle organization (GO:0071827) | 3.14236397 |
126 | vitamin D metabolic process (GO:0042359) | 3.10941086 |
127 | protein-lipid complex assembly (GO:0065005) | 3.00785395 |
128 | protein-lipid complex subunit organization (GO:0071825) | 2.99448329 |
129 | regulation of cholesterol storage (GO:0010885) | 2.98824280 |
130 | positive regulation of bone remodeling (GO:0046852) | 2.98383111 |
131 | positive regulation of bone resorption (GO:0045780) | 2.98383111 |
132 | negative regulation of blood coagulation (GO:0030195) | 2.97616127 |
133 | negative regulation of hemostasis (GO:1900047) | 2.97616127 |
134 | blood coagulation, intrinsic pathway (GO:0007597) | 2.94074039 |
135 | lipoprotein transport (GO:0042953) | 2.93391749 |
136 | lipoprotein metabolic process (GO:0042157) | 2.89595743 |
137 | positive regulation of lipid catabolic process (GO:0050996) | 2.86049302 |
138 | alkaloid metabolic process (GO:0009820) | 2.84316022 |
139 | regulation of cholesterol transport (GO:0032374) | 2.82330128 |
140 | regulation of sterol transport (GO:0032371) | 2.82330128 |
141 | response to thyroid hormone (GO:0097066) | 2.78432514 |
142 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.77395586 |
143 | negative regulation of coagulation (GO:0050819) | 2.77039445 |
144 | oxidative demethylation (GO:0070989) | 2.76582349 |
145 | neutrophil activation involved in immune response (GO:0002283) | 2.72810520 |
146 | negative regulation of lipid transport (GO:0032369) | 2.70825316 |
147 | glucose 6-phosphate metabolic process (GO:0051156) | 2.70700420 |
148 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.69750287 |
149 | vitamin biosynthetic process (GO:0009110) | 2.68017630 |
150 | regulation of monocyte differentiation (GO:0045655) | 2.66965678 |
151 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.62893733 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.29066849 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.10447989 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.73897445 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41467634 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.13525493 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.89517060 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.82075634 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.95363363 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.85946103 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.07870418 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.01685904 |
12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.52626753 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41301794 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25225276 |
15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11260466 |
16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10169554 |
17 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07390650 |
18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7516669 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68397795 |
20 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.64541200 |
21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63182991 |
22 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59953207 |
23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57522779 |
24 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53469331 |
25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51936420 |
26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51609648 |
27 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49182451 |
28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48175940 |
29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47815668 |
30 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.47081209 |
31 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46576164 |
32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45909818 |
33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37369984 |
34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36540832 |
35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36096169 |
36 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32872269 |
37 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.25690945 |
38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24822466 |
39 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.24306147 |
40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23892312 |
41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23335639 |
42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21948931 |
43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20330306 |
44 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18875615 |
45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18663728 |
46 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18368246 |
47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17181687 |
48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15667236 |
49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14782512 |
50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14728051 |
51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14598110 |
52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11263269 |
53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08587979 |
54 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08374427 |
55 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08370099 |
56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08114211 |
57 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06757836 |
58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05738753 |
59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05645109 |
60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05531939 |
61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05372159 |
62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04005256 |
63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02528801 |
64 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02497762 |
65 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01935656 |
66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01392368 |
67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01203870 |
68 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00856654 |
69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00227362 |
70 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99478202 |
71 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98965067 |
72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98155360 |
73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96751222 |
74 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95896622 |
75 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91455218 |
76 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90830543 |
77 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90572922 |
78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90221764 |
79 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.90079056 |
80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89425628 |
81 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89009091 |
82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88811697 |
83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86596442 |
84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86318795 |
85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86277833 |
86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86273776 |
87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86077681 |
88 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85069410 |
89 | MAF_26560356_Chip-Seq_TH1_Human | 0.83365277 |
90 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.82915238 |
91 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80805351 |
92 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80426303 |
93 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78819360 |
94 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77414363 |
95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74568529 |
96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73646803 |
97 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73073517 |
98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70905268 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70381891 |
100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69326910 |
101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.69211185 |
102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69009307 |
103 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68924868 |
104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.68345212 |
105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68042302 |
106 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64921359 |
107 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64780760 |
108 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64247332 |
109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.63807269 |
110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.62864291 |
111 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.61905046 |
112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.61790901 |
113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.61210971 |
114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61200784 |
115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60742398 |
116 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.59043037 |
117 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.59018762 |
118 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.58016606 |
119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57047542 |
120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56490209 |
121 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.56122128 |
122 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.53718068 |
123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.53690604 |
124 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.53619012 |
125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.53144404 |
126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.53144404 |
127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52605721 |
128 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50855686 |
129 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.50712781 |
130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.49598613 |
131 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49098083 |
132 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.46282293 |
133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46228420 |
134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45888943 |
135 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.45568062 |
136 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45021035 |
137 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.44243237 |
138 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.44179655 |
139 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.44117617 |
140 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.44060333 |
141 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.43538294 |
142 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.42943925 |
143 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42745275 |
144 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.42722482 |
145 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.42060976 |
146 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.41804355 |
147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41587914 |
148 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.41283253 |
149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.41195962 |
150 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.40894238 |
151 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40894045 |
152 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.40671810 |
153 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.40244240 |
154 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.40098066 |
155 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.40054389 |
156 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40044879 |
157 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.39802946 |
158 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.39767593 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.18832753 |
2 | MP0005360_urolithiasis | 7.95773468 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.12429068 |
4 | MP0005365_abnormal_bile_salt | 5.95696432 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.08368612 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.97993650 |
7 | MP0003252_abnormal_bile_duct | 3.86660990 |
8 | MP0010329_abnormal_lipoprotein_level | 3.34675823 |
9 | MP0005332_abnormal_amino_acid | 3.22448599 |
10 | MP0003195_calcinosis | 3.14965605 |
11 | MP0009840_abnormal_foam_cell | 2.96996224 |
12 | MP0005083_abnormal_biliary_tract | 2.78761371 |
13 | MP0004019_abnormal_vitamin_homeostasis | 2.68056393 |
14 | MP0001666_abnormal_nutrient_absorption | 2.47796566 |
15 | MP0003172_abnormal_lysosome_physiology | 2.43085883 |
16 | MP0002138_abnormal_hepatobiliary_system | 2.34547109 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.27910085 |
18 | MP0000609_abnormal_liver_physiology | 2.05812330 |
19 | MP0002118_abnormal_lipid_homeostasis | 2.02751916 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.86438261 |
21 | MP0002419_abnormal_innate_immunity | 1.77315184 |
22 | MP0001764_abnormal_homeostasis | 1.73875347 |
23 | MP0003868_abnormal_feces_composition | 1.73110340 |
24 | MP0003183_abnormal_peptide_metabolism | 1.71199116 |
25 | MP0009643_abnormal_urine_homeostasis | 1.68899235 |
26 | MP0001835_abnormal_antigen_presentation | 1.68088610 |
27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64633999 |
28 | MP0003303_peritoneal_inflammation | 1.64439894 |
29 | MP0009785_altered_susceptibility_to | 1.56410366 |
30 | MP0002148_abnormal_hypersensitivity_rea | 1.55932496 |
31 | MP0005451_abnormal_body_composition | 1.52885725 |
32 | MP0005025_abnormal_response_to | 1.52174329 |
33 | MP0003186_abnormal_redox_activity | 1.41136928 |
34 | MP0010234_abnormal_vibrissa_follicle | 1.40276157 |
35 | MP0010155_abnormal_intestine_physiology | 1.37698425 |
36 | MP0005636_abnormal_mineral_homeostasis | 1.34469195 |
37 | MP0009697_abnormal_copulation | 1.33017039 |
38 | MP0003011_delayed_dark_adaptation | 1.27468079 |
39 | MP0005671_abnormal_response_to | 1.25384755 |
40 | MP0001790_abnormal_immune_system | 1.22634467 |
41 | MP0005387_immune_system_phenotype | 1.22634467 |
42 | MP0002998_abnormal_bone_remodeling | 1.15676146 |
43 | MP0000598_abnormal_liver_morphology | 1.15390002 |
44 | MP0005000_abnormal_immune_tolerance | 1.14562943 |
45 | MP0001533_abnormal_skeleton_physiology | 1.13218282 |
46 | MP0003656_abnormal_erythrocyte_physiolo | 1.11649396 |
47 | MP0000343_altered_response_to | 1.09053473 |
48 | MP0002452_abnormal_antigen_presenting | 1.09036647 |
49 | MP0005647_abnormal_sex_gland | 1.06527875 |
50 | MP0008260_abnormal_autophagy | 1.04359513 |
51 | MP0009764_decreased_sensitivity_to | 1.03899131 |
52 | MP0005670_abnormal_white_adipose | 1.02830676 |
53 | MP0009333_abnormal_splenocyte_physiolog | 1.02461795 |
54 | MP0004043_abnormal_pH_regulation | 1.01603719 |
55 | MP0000604_amyloidosis | 1.00655832 |
56 | MP0001756_abnormal_urination | 0.99699514 |
57 | MP0003705_abnormal_hypodermis_morpholog | 0.98401989 |
58 | MP0003879_abnormal_hair_cell | 0.98241937 |
59 | MP0006036_abnormal_mitochondrial_physio | 0.96311905 |
60 | MP0002723_abnormal_immune_serum | 0.95106229 |
61 | MP0009763_increased_sensitivity_to | 0.92756473 |
62 | MP0001800_abnormal_humoral_immune | 0.92694877 |
63 | MP0005084_abnormal_gallbladder_morpholo | 0.91027224 |
64 | MP0009642_abnormal_blood_homeostasis | 0.90799408 |
65 | MP0008469_abnormal_protein_level | 0.89330313 |
66 | MP0002876_abnormal_thyroid_physiology | 0.86140384 |
67 | MP0002136_abnormal_kidney_physiology | 0.83878021 |
68 | MP0005408_hypopigmentation | 0.83763864 |
69 | MP0005310_abnormal_salivary_gland | 0.83464582 |
70 | MP0002254_reproductive_system_inflammat | 0.81573410 |
71 | MP0004947_skin_inflammation | 0.81162219 |
72 | MP0000858_altered_metastatic_potential | 0.80982812 |
73 | MP0002420_abnormal_adaptive_immunity | 0.80107634 |
74 | MP0001819_abnormal_immune_cell | 0.79537829 |
75 | MP0004883_abnormal_blood_vessel | 0.78546708 |
76 | MP0001545_abnormal_hematopoietic_system | 0.78379138 |
77 | MP0005397_hematopoietic_system_phenotyp | 0.78379138 |
78 | MP0000685_abnormal_immune_system | 0.77504281 |
79 | MP0010368_abnormal_lymphatic_system | 0.77317741 |
80 | MP0002078_abnormal_glucose_homeostasis | 0.77191385 |
81 | MP0001853_heart_inflammation | 0.76603403 |
82 | MP0001727_abnormal_embryo_implantation | 0.76507381 |
83 | MP0005376_homeostasis/metabolism_phenot | 0.76278252 |
84 | MP0003866_abnormal_defecation | 0.75117546 |
85 | MP0005535_abnormal_body_temperature | 0.74349614 |
86 | MP0005220_abnormal_exocrine_pancreas | 0.73994772 |
87 | MP0000920_abnormal_myelination | 0.73512203 |
88 | MP0009765_abnormal_xenobiotic_induced | 0.73505635 |
89 | MP0001765_abnormal_ion_homeostasis | 0.73237533 |
90 | MP0001661_extended_life_span | 0.71554615 |
91 | MP0002971_abnormal_brown_adipose | 0.69572141 |
92 | MP0000678_abnormal_parathyroid_gland | 0.68517474 |
93 | MP0002090_abnormal_vision | 0.66745954 |
94 | MP0003448_altered_tumor_morphology | 0.66451799 |
95 | MP0005257_abnormal_intraocular_pressure | 0.64719104 |
96 | MP0005164_abnormal_response_to | 0.63504049 |
97 | MP0003453_abnormal_keratinocyte_physiol | 0.62606087 |
98 | MP0005334_abnormal_fat_pad | 0.62248950 |
99 | MP0003329_amyloid_beta_deposits | 0.61775886 |
100 | MP0002928_abnormal_bile_duct | 0.61730527 |
101 | MP0005266_abnormal_metabolism | 0.60041334 |
102 | MP0004130_abnormal_muscle_cell | 0.59795603 |
103 | MP0006035_abnormal_mitochondrial_morpho | 0.59050157 |
104 | MP0009053_abnormal_anal_canal | 0.56005018 |
105 | MP0003690_abnormal_glial_cell | 0.55321928 |
106 | MP0005395_other_phenotype | 0.54233035 |
107 | MP0003638_abnormal_response/metabolism_ | 0.51767630 |
108 | MP0005666_abnormal_adipose_tissue | 0.49365090 |
109 | MP0000639_abnormal_adrenal_gland | 0.48802255 |
110 | MP0005058_abnormal_lysosome_morphology | 0.48484983 |
111 | MP0005410_abnormal_fertilization | 0.46585046 |
112 | MP0005448_abnormal_energy_balance | 0.45935426 |
113 | MP0000230_abnormal_systemic_arterial | 0.45257305 |
114 | MP0002168_other_aberrant_phenotype | 0.45075871 |
115 | MP0005464_abnormal_platelet_physiology | 0.44959366 |
116 | MP0003953_abnormal_hormone_level | 0.43880635 |
117 | MP0003724_increased_susceptibility_to | 0.41151526 |
118 | MP0008874_decreased_physiological_sensi | 0.41025181 |
119 | MP0008873_increased_physiological_sensi | 0.40827028 |
120 | MP0003718_maternal_effect | 0.40071734 |
121 | MP0002796_impaired_skin_barrier | 0.39194886 |
122 | MP0009672_abnormal_birth_weight | 0.37354008 |
123 | MP0008872_abnormal_physiological_respon | 0.36644293 |
124 | MP0004782_abnormal_surfactant_physiolog | 0.36425386 |
125 | MP0002135_abnormal_kidney_morphology | 0.36192297 |
126 | MP0003075_altered_response_to | 0.36053807 |
127 | MP0002837_dystrophic_cardiac_calcinosis | 0.35026273 |
128 | MP0002822_catalepsy | 0.34452051 |
129 | MP0000538_abnormal_urinary_bladder | 0.34048483 |
130 | MP0005166_decreased_susceptibility_to | 0.33608094 |
131 | MP0009115_abnormal_fat_cell | 0.32319741 |
132 | MP0003436_decreased_susceptibility_to | 0.31383164 |
133 | MP0004264_abnormal_extraembryonic_tissu | 0.30655222 |
134 | MP0001845_abnormal_inflammatory_respons | 0.29253190 |
135 | MP0003300_gastrointestinal_ulcer | 0.28992459 |
136 | MP0002970_abnormal_white_adipose | 0.28042643 |
137 | MP0000579_abnormal_nail_morphology | 0.26144561 |
138 | MP0000249_abnormal_blood_vessel | 0.25978040 |
139 | MP0006082_CNS_inflammation | 0.25298368 |
140 | MP0003959_abnormal_lean_body | 0.24507810 |
141 | MP0008961_abnormal_basal_metabolism | 0.23158803 |
142 | MP0009384_cardiac_valve_regurgitation | 0.22856196 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.16493210 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.73914320 |
3 | Deep venous thrombosis (HP:0002625) | 6.68744338 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 6.56301424 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.56301424 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.56301424 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.30662118 |
8 | Xanthomatosis (HP:0000991) | 5.96166427 |
9 | Prolonged partial thromboplastin time (HP:0003645) | 5.84153968 |
10 | Hypobetalipoproteinemia (HP:0003563) | 5.75802527 |
11 | Hyperlipoproteinemia (HP:0010980) | 5.01094529 |
12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.76906658 |
13 | Increased cerebral lipofuscin (HP:0011813) | 4.75624739 |
14 | Complement deficiency (HP:0004431) | 4.70834117 |
15 | Hyperammonemia (HP:0001987) | 4.69714938 |
16 | Hyperglycinuria (HP:0003108) | 4.49833465 |
17 | Hyperglycinemia (HP:0002154) | 4.46298603 |
18 | Joint hemorrhage (HP:0005261) | 4.44975423 |
19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.39164523 |
20 | Hypolipoproteinemia (HP:0010981) | 4.34984392 |
21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.32635209 |
22 | Abnormality of glycine metabolism (HP:0010895) | 4.28315605 |
23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.28315605 |
24 | * Ketosis (HP:0001946) | 4.27176143 |
25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.14680261 |
26 | Epidermoid cyst (HP:0200040) | 4.08688217 |
27 | Abnormality of methionine metabolism (HP:0010901) | 4.04765679 |
28 | Abnormality of the common coagulation pathway (HP:0010990) | 4.02453113 |
29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.95889570 |
30 | Hypoalphalipoproteinemia (HP:0003233) | 3.85682654 |
31 | Fat malabsorption (HP:0002630) | 3.80621731 |
32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78976089 |
33 | Hypoglycemic coma (HP:0001325) | 3.75582954 |
34 | Gout (HP:0001997) | 3.70978067 |
35 | Vacuolated lymphocytes (HP:0001922) | 3.70742304 |
36 | Abnormality of macrophages (HP:0004311) | 3.65528084 |
37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64375313 |
38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.51614897 |
39 | Ketoacidosis (HP:0001993) | 3.48343593 |
40 | Eczematoid dermatitis (HP:0000976) | 3.45640756 |
41 | Abnormality of complement system (HP:0005339) | 3.40025023 |
42 | Abnormality of purine metabolism (HP:0004352) | 3.37934300 |
43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.37183690 |
44 | Conjugated hyperbilirubinemia (HP:0002908) | 3.36678999 |
45 | Dysostosis multiplex (HP:0000943) | 3.34927563 |
46 | Delayed CNS myelination (HP:0002188) | 3.30934765 |
47 | Hypercholesterolemia (HP:0003124) | 3.29658878 |
48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.29516578 |
49 | Hyperbilirubinemia (HP:0002904) | 3.21396720 |
50 | Loss of speech (HP:0002371) | 3.20957908 |
51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.16690124 |
52 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.16690124 |
53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.16690124 |
54 | Abnormality of serum amino acid levels (HP:0003112) | 3.10932610 |
55 | Mucopolysacchariduria (HP:0008155) | 3.09298650 |
56 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.09298650 |
57 | Purpura (HP:0000979) | 3.02096029 |
58 | Recurrent abscess formation (HP:0002722) | 2.96592299 |
59 | Hepatocellular carcinoma (HP:0001402) | 2.95973005 |
60 | Vascular calcification (HP:0004934) | 2.92378895 |
61 | Dicarboxylic aciduria (HP:0003215) | 2.84464530 |
62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.84464530 |
63 | J-shaped sella turcica (HP:0002680) | 2.83096450 |
64 | * Metabolic acidosis (HP:0001942) | 2.82840321 |
65 | Steatorrhea (HP:0002570) | 2.81945648 |
66 | Spontaneous abortion (HP:0005268) | 2.75856908 |
67 | Generalized aminoaciduria (HP:0002909) | 2.74508902 |
68 | Axonal loss (HP:0003447) | 2.73484948 |
69 | Proximal tubulopathy (HP:0000114) | 2.73044122 |
70 | Alkalosis (HP:0001948) | 2.68939072 |
71 | * Lethargy (HP:0001254) | 2.67981597 |
72 | Nephritis (HP:0000123) | 2.66662407 |
73 | Increased serum ferritin (HP:0003281) | 2.63008786 |
74 | Increased purine levels (HP:0004368) | 2.62367703 |
75 | Hyperuricemia (HP:0002149) | 2.62367703 |
76 | Disinhibition (HP:0000734) | 2.61807252 |
77 | Cardiovascular calcification (HP:0011915) | 2.58632408 |
78 | Myocardial infarction (HP:0001658) | 2.56586018 |
79 | Recurrent bacterial skin infections (HP:0005406) | 2.55456273 |
80 | Malnutrition (HP:0004395) | 2.54143775 |
81 | Hypophosphatemia (HP:0002148) | 2.50509821 |
82 | Cerebral edema (HP:0002181) | 2.49510986 |
83 | Hypochromic microcytic anemia (HP:0004840) | 2.48775314 |
84 | Systemic lupus erythematosus (HP:0002725) | 2.48733972 |
85 | Thin bony cortex (HP:0002753) | 2.45872411 |
86 | Spastic diplegia (HP:0001264) | 2.45229105 |
87 | Skin nodule (HP:0200036) | 2.44751943 |
88 | Widely patent fontanelles and sutures (HP:0004492) | 2.44239737 |
89 | Neonatal onset (HP:0003623) | 2.43756930 |
90 | Enlarged kidneys (HP:0000105) | 2.42967320 |
91 | Protuberant abdomen (HP:0001538) | 2.42668356 |
92 | Vomiting (HP:0002013) | 2.34684288 |
93 | Nausea (HP:0002018) | 2.34223530 |
94 | * Irritability (HP:0000737) | 2.32908233 |
95 | Prolonged neonatal jaundice (HP:0006579) | 2.30696113 |
96 | Hypoglycemic seizures (HP:0002173) | 2.30269725 |
97 | Abnormality of iron homeostasis (HP:0011031) | 2.27855225 |
98 | Hydroxyprolinuria (HP:0003080) | 2.26338555 |
99 | Abnormality of proline metabolism (HP:0010907) | 2.26338555 |
100 | Rickets (HP:0002748) | 2.25910824 |
101 | Acanthocytosis (HP:0001927) | 2.24962254 |
102 | Abnormal gallbladder physiology (HP:0012438) | 2.24932108 |
103 | Cholecystitis (HP:0001082) | 2.24932108 |
104 | Late onset (HP:0003584) | 2.24749900 |
105 | Abnormality of urine glucose concentration (HP:0011016) | 2.24628043 |
106 | Glycosuria (HP:0003076) | 2.24628043 |
107 | Neurofibrillary tangles (HP:0002185) | 2.23624183 |
108 | Sensorimotor neuropathy (HP:0007141) | 2.23123835 |
109 | Mitral stenosis (HP:0001718) | 2.21735757 |
110 | Pancreatitis (HP:0001733) | 2.21556030 |
111 | Glomerulonephritis (HP:0000099) | 2.20207315 |
112 | Retinal atrophy (HP:0001105) | 2.20035811 |
113 | Abdominal distention (HP:0003270) | 2.19141762 |
114 | Abnormal gallbladder morphology (HP:0012437) | 2.18982645 |
115 | Bone pain (HP:0002653) | 2.18507278 |
116 | Abnormality of the periventricular white matter (HP:0002518) | 2.16351791 |
117 | Cholelithiasis (HP:0001081) | 2.14760284 |
118 | Metaphyseal irregularity (HP:0003025) | 2.09184107 |
119 | Pathologic fracture (HP:0002756) | 2.07977472 |
120 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.07695043 |
121 | Diminished motivation (HP:0000745) | 2.04985248 |
122 | Brushfield spots (HP:0001088) | 2.04961371 |
123 | Esophageal varix (HP:0002040) | 2.03648396 |
124 | Amyloidosis (HP:0011034) | 2.02287704 |
125 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02238392 |
126 | Gingivitis (HP:0000230) | 2.00715824 |
127 | Thrombophlebitis (HP:0004418) | 2.00687975 |
128 | Progressive neurologic deterioration (HP:0002344) | 1.98226194 |
129 | Neuronal loss in central nervous system (HP:0002529) | 1.96828122 |
130 | Apathy (HP:0000741) | 1.96570717 |
131 | Elevated alkaline phosphatase (HP:0003155) | 1.96216385 |
132 | Cardiomegaly (HP:0001640) | 1.95388648 |
133 | Menorrhagia (HP:0000132) | 1.95093946 |
134 | Opisthotonus (HP:0002179) | 1.94119415 |
135 | Hypophosphatemic rickets (HP:0004912) | 1.92831343 |
136 | Mutism (HP:0002300) | 1.92003568 |
137 | Hemorrhage of the eye (HP:0011885) | 1.91144063 |
138 | Obstructive lung disease (HP:0006536) | 1.91089862 |
139 | Chronic obstructive pulmonary disease (HP:0006510) | 1.91089862 |
140 | Gingival bleeding (HP:0000225) | 1.90550098 |
141 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90447060 |
142 | Nephrolithiasis (HP:0000787) | 1.89787980 |
143 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89368496 |
144 | Interstitial pulmonary disease (HP:0006530) | 1.87893353 |
145 | Pulmonary embolism (HP:0002204) | 1.87616957 |
146 | Petechiae (HP:0000967) | 1.86868404 |
147 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86781355 |
148 | Abnormality of the gallbladder (HP:0005264) | 1.86193491 |
149 | Abnormal cartilage morphology (HP:0002763) | 1.85627443 |
150 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84434318 |
151 | Confusion (HP:0001289) | 1.83714555 |
152 | Renal cortical cysts (HP:0000803) | 1.81944679 |
153 | Autoimmune thrombocytopenia (HP:0001973) | 1.81892985 |
154 | Peripheral demyelination (HP:0011096) | 1.80766444 |
155 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.78086192 |
156 | Hepatosplenomegaly (HP:0001433) | 1.77957396 |
157 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76757232 |
158 | Thoracic kyphosis (HP:0002942) | 1.76624534 |
159 | Multiple lipomas (HP:0001012) | 1.75799378 |
160 | Asymmetric septal hypertrophy (HP:0001670) | 1.74499551 |
161 | Cerebral inclusion bodies (HP:0100314) | 1.68913878 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.29519373 |
2 | FGFR4 | 4.22025859 |
3 | ERN1 | 3.88806922 |
4 | SIK1 | 3.72215783 |
5 | BLK | 2.87816783 |
6 | RIPK4 | 2.83660129 |
7 | WNK4 | 2.80788102 |
8 | WNK3 | 2.64477780 |
9 | INSRR | 2.62110714 |
10 | TAOK3 | 2.56091613 |
11 | ERBB4 | 2.48569585 |
12 | TESK2 | 2.45560691 |
13 | ACVR1B | 2.39471558 |
14 | PDK4 | 2.28586452 |
15 | PDK3 | 2.28586452 |
16 | MST1R | 2.15846691 |
17 | NME2 | 1.98203502 |
18 | MAP2K4 | 1.95360762 |
19 | PRPF4B | 1.87056715 |
20 | OXSR1 | 1.84235149 |
21 | PKN2 | 1.80011098 |
22 | MAPK11 | 1.77516930 |
23 | EPHA2 | 1.71993678 |
24 | MAP4K1 | 1.69250049 |
25 | STK38L | 1.68649879 |
26 | PIK3CG | 1.66316064 |
27 | TRIB3 | 1.60486589 |
28 | TESK1 | 1.59691515 |
29 | FLT3 | 1.54317522 |
30 | ZAP70 | 1.48949181 |
31 | MAPKAPK3 | 1.44528138 |
32 | LATS1 | 1.41996239 |
33 | PRKG2 | 1.40979670 |
34 | PINK1 | 1.40947983 |
35 | GRK7 | 1.37806234 |
36 | TYK2 | 1.36893799 |
37 | ABL2 | 1.35947887 |
38 | FRK | 1.35895074 |
39 | PTK6 | 1.35373948 |
40 | PDK2 | 1.33998163 |
41 | SCYL2 | 1.30076906 |
42 | TAOK1 | 1.27215778 |
43 | DAPK2 | 1.22743655 |
44 | NEK9 | 1.19276441 |
45 | FGR | 1.19032876 |
46 | RPS6KA2 | 1.18851946 |
47 | MAPK15 | 1.18014511 |
48 | GRK6 | 1.15315427 |
49 | KDR | 1.11961245 |
50 | MAP3K7 | 1.06942201 |
51 | PRKAA2 | 1.06439612 |
52 | MATK | 1.06383445 |
53 | MAP2K2 | 1.05013625 |
54 | IRAK4 | 1.04969625 |
55 | SMG1 | 1.03977143 |
56 | PAK4 | 1.03932433 |
57 | JAK2 | 1.03549420 |
58 | DYRK1B | 1.01293881 |
59 | NEK6 | 0.99780434 |
60 | MAP3K12 | 0.99281812 |
61 | MAP2K3 | 0.98089829 |
62 | CDC42BPA | 0.97982726 |
63 | EPHB1 | 0.97832295 |
64 | FGFR2 | 0.97212917 |
65 | PIK3CA | 0.96886313 |
66 | MAP3K13 | 0.93845147 |
67 | STK39 | 0.93656419 |
68 | IKBKB | 0.92954934 |
69 | MAP3K3 | 0.92269339 |
70 | MAP3K2 | 0.88747492 |
71 | PRKCZ | 0.87139758 |
72 | TIE1 | 0.86132197 |
73 | ICK | 0.85762016 |
74 | TBK1 | 0.84422840 |
75 | LIMK1 | 0.83840538 |
76 | MAPK4 | 0.83660818 |
77 | TNK2 | 0.81406765 |
78 | ERBB2 | 0.80375619 |
79 | SGK223 | 0.78631304 |
80 | SGK494 | 0.78631304 |
81 | MAP3K10 | 0.78620581 |
82 | SGK3 | 0.78036227 |
83 | GSK3A | 0.76635458 |
84 | PRKAA1 | 0.76471719 |
85 | RPS6KL1 | 0.76290611 |
86 | RPS6KC1 | 0.76290611 |
87 | KSR2 | 0.75324440 |
88 | MET | 0.73872067 |
89 | JAK1 | 0.73528557 |
90 | MAP3K14 | 0.73436312 |
91 | MAP3K11 | 0.72576673 |
92 | MUSK | 0.72315033 |
93 | MAP2K6 | 0.68941623 |
94 | CHUK | 0.67666198 |
95 | LRRK2 | 0.66991224 |
96 | PIM2 | 0.66866810 |
97 | LYN | 0.65450193 |
98 | SGK2 | 0.64979553 |
99 | STK38 | 0.64891484 |
100 | MAPK12 | 0.64265972 |
101 | PDPK1 | 0.64172617 |
102 | BMPR2 | 0.64043169 |
103 | ARAF | 0.63226039 |
104 | MAPKAPK2 | 0.62559020 |
105 | DDR2 | 0.62512842 |
106 | CSK | 0.62469893 |
107 | * PRKACG | 0.60400378 |
108 | CDK6 | 0.59986478 |
109 | PTK2 | 0.59591978 |
110 | TGFBR2 | 0.59464229 |
111 | RPS6KA6 | 0.58327353 |
112 | HCK | 0.54857987 |
113 | SYK | 0.54588475 |
114 | CAMK2G | 0.53736653 |
115 | NEK1 | 0.53417022 |
116 | RIPK1 | 0.52898061 |
117 | SIK3 | 0.52309008 |
118 | PDK1 | 0.52036124 |
119 | JAK3 | 0.51300716 |
120 | EPHA3 | 0.51051240 |
121 | FES | 0.50662651 |
122 | RPS6KB2 | 0.47929041 |
123 | BTK | 0.47328472 |
124 | FER | 0.46701400 |
125 | IRAK3 | 0.45512968 |
126 | LCK | 0.45435072 |
127 | CAMKK1 | 0.45270952 |
128 | CSF1R | 0.42712633 |
129 | PRKCQ | 0.42027615 |
130 | IRAK1 | 0.40510670 |
131 | MAPK7 | 0.37815114 |
132 | CAMK1D | 0.36558468 |
133 | PRKCG | 0.35917791 |
134 | MTOR | 0.35617009 |
135 | IGF1R | 0.35223332 |
136 | IKBKE | 0.35075015 |
137 | FGFR3 | 0.34238796 |
138 | MAP3K5 | 0.33584031 |
139 | PTK2B | 0.32870863 |
140 | GRK1 | 0.31838260 |
141 | IRAK2 | 0.30474703 |
142 | CDK4 | 0.29025015 |
143 | CSNK1G1 | 0.28504074 |
144 | MAP3K6 | 0.28190290 |
145 | MAP2K1 | 0.24726865 |
146 | EGFR | 0.24400150 |
147 | TAOK2 | 0.24031153 |
148 | EPHA4 | 0.23723983 |
149 | RET | 0.22709667 |
150 | STK3 | 0.22116282 |
151 | * PRKCA | 0.20327411 |
152 | CAMK4 | 0.19284873 |
153 | MAP3K1 | 0.19112988 |
154 | PBK | 0.15780559 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.19237323 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44396974 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.37130521 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31342064 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93863366 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.77863210 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69722856 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62983699 |
9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56261725 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56096603 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51736250 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46929139 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42322655 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.36830947 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.20254279 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19049021 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07003620 |
18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87986464 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87287782 |
20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87076614 |
21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86658830 |
22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84193469 |
23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83088892 |
24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82459237 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76301567 |
26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69811497 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68616673 |
28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68147724 |
29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64186822 |
30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62945929 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61775160 |
32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59807409 |
33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56715417 |
34 | Bile secretion_Homo sapiens_hsa04976 | 1.53806937 |
35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51920125 |
36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51185332 |
37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43296770 |
38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35436350 |
39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35269473 |
40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31869785 |
41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31472077 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30085592 |
43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28310488 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25374757 |
45 | Asthma_Homo sapiens_hsa05310 | 1.22860055 |
46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22694715 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20839546 |
48 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.20751125 |
49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15257644 |
50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13363067 |
51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12564802 |
52 | ABC transporters_Homo sapiens_hsa02010 | 1.12043251 |
53 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09000367 |
54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07242985 |
55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07010810 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05364308 |
57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04997307 |
58 | Pertussis_Homo sapiens_hsa05133 | 1.04927768 |
59 | Phagosome_Homo sapiens_hsa04145 | 1.04907187 |
60 | Allograft rejection_Homo sapiens_hsa05330 | 1.04148210 |
61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99915415 |
62 | Tuberculosis_Homo sapiens_hsa05152 | 0.95461576 |
63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92167087 |
64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91671753 |
65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.91355256 |
66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89873189 |
67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89794274 |
68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89666592 |
69 | Lysine degradation_Homo sapiens_hsa00310 | 0.88334392 |
70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85724684 |
71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82915356 |
72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79444444 |
73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77908662 |
74 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77340271 |
75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76240706 |
76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73671696 |
77 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66483426 |
78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64645796 |
79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63807833 |
80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61850435 |
81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59170840 |
82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56452207 |
83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52967722 |
84 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.49770722 |
85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47890599 |
86 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41036985 |
87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40069368 |
88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.38455770 |
89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36492265 |
90 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33637771 |
91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32261111 |
92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31173101 |
93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30753543 |
94 | Legionellosis_Homo sapiens_hsa05134 | 0.29596353 |
95 | Amoebiasis_Homo sapiens_hsa05146 | 0.28051269 |
96 | Influenza A_Homo sapiens_hsa05164 | 0.27414847 |
97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25700092 |
98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.25292384 |
99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24869170 |
100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.23510701 |
101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22158443 |
102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21315072 |
103 | Insulin resistance_Homo sapiens_hsa04931 | 0.21041843 |
104 | Prion diseases_Homo sapiens_hsa05020 | 0.20279150 |
105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16981393 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14829469 |
107 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14217539 |
108 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07516455 |
109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2149161 |
110 | Lysosome_Homo sapiens_hsa04142 | -0.2054503 |
111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2038500 |
112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1923733 |
113 | Hepatitis C_Homo sapiens_hsa05160 | -0.1884903 |
114 | * Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1880643 |
115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1776859 |
116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1759564 |
117 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1757904 |
118 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1626686 |
119 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1348774 |
120 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1153447 |
121 | Mineral absorption_Homo sapiens_hsa04978 | -0.1049010 |
122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1037250 |
123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1006832 |
124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0870450 |
125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0662612 |
126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0625794 |
127 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0509100 |
128 | * AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0306056 |
129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0291523 |
130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0187852 |